During the past decade, Encino Research Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Encino Research Center" #1 sponsor was "AOBiome LLC" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Bausch Health Americas, Inc." with 1 trials sponsored, "BioMimetix JV, LLC" with 1 trials sponsored and "Botanix Pharmaceuticals" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Encino Research Center" #1 collaborator was "Prosoft Clinical" with 1 trials as a collaborator, "Translational Research in Oncology" with 1 trials as a collaborator, "Veristat, Inc." with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Encino Research Center" are "Atopic Dermatitis" (4 trials), "Acne Vulgaris" (3 trials), "Psoriasis" (3 trials), "Actinic Keratosis" (1 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "Encino Research Center" in a lesser frequency.

Most popular intervention types in "Encino Research Center" are "Drug" (10 trials), "Biological" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Vehicle" (3 trials), "B244" (2 trials), "Placebo" (2 trials), "Adalimumab" (1 trials) and "Apremilast (CC-10004)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Encino Research Center" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Encino Research Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Encino Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Encino Research Center, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".